Statistics for 1-Aryl-3-[ 4-( thieno[3,2-d]pyrimidin-4-yloxy )phenyl]ureas as VEG FR2 inhibitors: synthesis, docking enzymatic and cellular assays
Total visits
| views | |
|---|---|
| 1-Aryl-3-[ 4-( thieno[3,2-d]pyrimidin-4-yloxy )phenyl]ureas as VEG FR2 inhibitors: synthesis, docking enzymatic and cellular assays | 361 |
Total visits per month
| views | |
|---|---|
| November 2024 | 1 |
| December 2024 | 4 |
| January 2025 | 3 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| Oral Nac. 32.pdf(legacy) | 173 |
| Oral Nac. 32.pdf | 7 |
| Oral Nac. 31.pdf(legacy) | 2 |
Top country views
| views | |
|---|---|
| United States | 121 |
| Germany | 85 |
| Portugal | 35 |
| China | 24 |
| Russia | 23 |
| France | 10 |
| Turkey | 8 |
| Belarus | 7 |
| United Kingdom | 6 |
| Ukraine | 6 |
| Netherlands | 5 |
| Brazil | 3 |
| Hong Kong SAR China | 3 |
| Poland | 3 |
| Singapore | 3 |
| Canada | 2 |
| Denmark | 2 |
| European Union | 2 |
| Italy | 2 |
| Latvia | 2 |
| Sweden | 2 |
| Switzerland | 1 |
| India | 1 |
| Japan | 1 |
| South Africa | 1 |